Filter
6485
Filtered Results: 6485
Text search:
place
of
delivery
Featured
Recommendations
584
New Publications
1924
Language
Document type
No document type
3894
Studies & Reports
949
Guidelines
734
Manuals
361
Strategic & Response Plan
259
Training Material
113
Fact sheets
78
Situation Updates
59
Infographics
12
Resource Platforms
11
Brochures
9
Online Courses
5
App
1
Countries / Regions
India
337
Global
260
Kenya
233
Sierra Leone
161
Ethiopia
149
Nigeria
146
Nepal
145
Uganda
138
South Africa
137
Liberia
135
Myanmar / Burma
126
Malawi
121
Bangladesh
120
Zambia
113
Western and Central Europe
113
Rwanda
105
Tanzania
99
Ghana
95
Syria
95
Africa
74
Ukraine
68
Namibia
62
Philippines
57
South Sudan
57
Zimbabwe
51
Congo, Democratic Republic of
50
Lesotho
48
South–East Asia Region
48
Latin America and the Carribbean
46
Haiti
42
Eastern Europe
39
Cambodia
37
Asia
37
Guinea
36
Indonesia
34
Senegal
31
West and Central Africa
31
Pakistan
30
Botswana
30
East and Southern Africa
30
Mozambique
28
Yemen
25
Afghanistan
24
Burkina Faso
21
Eswatini/ Swaziland
21
Jordan
19
Lebanon
18
Sudan
18
Middle East and North Africa
18
Central African Republic
17
Eastern Europe and Central Asia
17
Venezuela
17
Benin
16
Western Pacific Region
16
Cameroon
15
Vietnam
14
Germany
13
Laos
13
Somalia
12
Russia
11
Mali
10
Brazil
10
Colombia
10
Moldova
10
USA
9
Thailand
9
Madagascar
9
Sri Lanka
9
Palestine
9
Iraq
8
Peru
8
Albania
8
Southern Africa
7
Iran
7
Georgia
7
China
6
Papua New Guinea
6
Burundi
6
Tajikistan
6
United Kingdom
6
Côte d’Ivoire / Ivory Coast
5
Turkey
5
Chile
5
Niger
4
Egypt
4
Chad
4
Gambia
4
Greece
4
Libya
4
Mexico
4
Fiji
4
Bhutan
4
Guinea-Bissau
3
North Macedonia
3
Ecuador
3
Paraguay
3
Poland
3
Armenia
3
Timor Leste/ East Timor
3
Kyrgyzstan
3
Kazakhstan
3
Turkmenistan
3
Jamaica
3
Saudi Arabia
2
Togo
2
Malaysia
2
Singapore
2
Argentina
2
Serbia
2
Hungary
2
Croatia
2
Honduras
2
El Salvador
2
Bolivia
2
Angola
2
Canada
2
Qatar
2
Estonia
2
Romania
2
Lithuania
2
Mauritius
2
Tunisia
2
Portugal
2
Spain
2
Azerbaijan
2
Belarus
2
Morocco
1
Ireland
1
Dominican Republic
1
Switzerland
1
Guatemala
1
Other region
1
Djibouti
1
Mongolia
1
Bulgaria
1
Uzbekistan
1
Australia
1
North America
1
Japan
1
Belgium
1
France
1
Maldives
1
Algeria
1
Israel
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
2681
Clinical Guidelines
437
Women & Child Health
402
Key Resources
367
Public Health
366
Capacity Building
149
Pharmacy & Technologies
60
Toolboxes
COVID-19
514
HIV
487
Mental Health
399
TB
266
Disability
253
Conflict
234
Caregiver
230
Planetary Health
196
Ebola
163
Rapid Response
163
Refugee
119
AMR
114
Pharmacy
108
Global Health Education
101
Natural Hazards
100
NTDs
93
NCDs
85
Health Financing Toolbox
52
Polio
41
Social Ethics
36
Specific Hazards
34
Cholera
31
Zika
27
Typhoon
6
Health Financing
3
South Sudan
2
Suicide is largely preventable. Unlike for many other health issues, the tools to significantly reduce the most tragic loss of life by suicide are available. With collective action to acknowledge and address this serious problem, as well as commitme...
Children in Kabwe are especially at risk because they are more likely to ingest lead dust when playing in the soil, their brains and bodies are still developing, and they absorb four to five times as much lead as adults. The consequences for children who are exposed to high levels ... lead and are not treated include reading and learning barriers or disabilities; behavioral problems; impaired growth; anemia; brain, liver, kidney, nerve, and stomach damage; coma and convulsions; and death. After prolonged exposure, the effects are irreversible. Lead also increases the risk of miscarriage and can be transmitted through both the placenta and breastmilk.
Progress in reducing tobacco use is a key indicator for measuring countries’ efforts to implement the WHO Framework Convention on Tobacco Control – target 3.a under the Sustainable Development Goals agenda. Countries have adopted this indicator to report progress also towards the tobacco reducti...
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk ...
Module 3
Counsellors
July 2017
Module 3: Counsellors. This module is for staff who counsel people as they consider PrEP or start taking PrEP and support them in coping with side-effects and adherence strategies. Those who counsel PrEP users may be lay, peer or professional counsellors and hea...
The WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination is intended to offer guidance on the prioritization of groups for vaccination when vaccine supply is limit...
1 March 2021 This roadmap aims to define the key questions users should consider to assess indoor ventilation and the major steps needed to reach recommended ventilation levels or simply improve indoor air quality (IAQ) in order to reduce the risk of...
A new brief published by the IFRC and Climate Centre today details the adverse impacts of climate change on human health and provides more detail on the second of four pillars ... action in the Red Cross Red Crescent Movement ambitions on climate.
WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention
recommended
2nd edition, July 2021. This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of cervical cancer. It includes some important shifts in WHO’s recommended approaches to cervical...
Connecting global priorities: biodiversity and human health: a state of knowledge review
an approach to optimize the global impact of COVID-19 vaccines, based on public health goals, global and national equity, and vaccine access and coverage scenarios, first issued 20 October 2020, updated: 13 November 2020, updated: 16 July 2021, late...
22 April 2022, This document provides updated interim recommendations on the use of masks by health workers providing care to patients with suspected or confirmed COVID-19. This update is prompted by new evidence around mask use and COVID-19 transmi...
Economic conditions in Syria are projected to continue to be mired by prolonged armed conflict, turmoil in Lebanon and Turkey, COVID-19, and the war in Ukraine. Subject to extraordinarily high uncertainty, we project that Syria’s real GDP will contract by 2.6 percent in 2022 (to US$ 15.5 billion i...
Concepte Note, June 2022
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders...
January 2020 to December 2021
Conflicts and disasters, including pandemics, affect women and men in all their diversity differently, and women and girls often suffer the most. Crisis-related hardships combine and compound pre-existing disadvantages, for example, they often cause women’s working conditions to worsen while incre...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as ... 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly replacing Delta worldwide – was considered Omicron has a substantial growth advantage, higher secondary attack rates and a higher observed reproduction number than Delta.
There is now significant evidence that immune evasion contributes to the rapid spread of Omicron. Other factors may be a shorter
serial interval (by about 0.8 to 1.2 days compared to Delta) and potential increased intrinsic transmission fitness . There is
growing evidence that with Omicron, there is lower vaccine effectiveness (VE) against infection and symptomatic disease soon after vaccination compared to Delta. There is also evidence of accelerated waning of VE over time of the primary series against infection and symptomatic disease for the studied vaccines. Further studies are required to better understand the drivers of transmission and declining incidence in various settings. These factors include the intrinsic transmission fitness properties of the virus, degree of immune evasion, vaccination coverage and level of vaccine-derived and post-infection immunity, levels of social mixing and degree of application of public health and social measures (PHSM).
